Top Markets
Coin of the day
InnoCan Pharma Corporation InnoCan Pharma Corporation

InnoCan Pharma Corporation

INNO
Rang in Aktien #33470
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to... InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
Aktienkurs
$1.69
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$7.59M
Veränderung (1 Tag)
2.22%
Veränderung (1 Jahr)
-84.04%
Land
CA
Handel InnoCan Pharma Corporation (INNO)

Kategorie

Dividendenrendite-Verlauf für InnoCan Pharma Corporation (INNO)
Dividendenrendite (TTM) von InnoCan Pharma Corporation (Aktienkürzel: INNO) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für InnoCan Pharma Corporation (INNO) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber